2-[(4-([(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino)phenyl)formamido]pentanedioic acid

CAS : 65165-92-6

Ref. 3D-QCA16592

Informations sur le produit

• Nom: 2-[(4-([(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino)phenyl)formamido]pentanedioic acid
• Synonymes: DL-Glutamicacid, N-[4-[[(2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-, Glutamic acid,N-[4-[[(2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]- (9CI)

Description

2-[(4-([(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino)phenyl)formamido]pentanedioic acid is a medicinal compound that has shown potential as an anticancer agent. It is an analog of inhibitors of kinases, which are enzymes that play a critical role in cancer cell growth and proliferation. This compound has been tested on human and Chinese hamster ovary cells and has been found to inhibit the activity of several kinases involved in tumor formation. Additionally, this compound induces apoptosis, or programmed cell death, in cancer cells by affecting the expression of certain proteins. The presence of this compound can be detected in urine samples collected from patients undergoing treatment with this inhibitor. Overall, 2-[(4-([(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino)phenyl)form

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 441.4 g/mol
• Formule: C₁₉H₁₉N₇O₆
• Degré de pureté: Min. 95%